Gut Registry

entity · release 2026-09-20

Akkermansia muciniphila

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Across the corpus

How this organism is actually sold

Printed CFU per serving
100,000,000 – 1,000,000,000; median 550,000,000. Measured on the 2 of 6 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
Forms
Capsule: 5 · Tablet or Pill: 1 · counted across the 6 of 6 published products whose label states a form
Brands carrying it
codeage (3) · solaray (1) · supersmart (1) · the-akkermansia-company (1)
Published product pages
6

Products

Published products carrying this organism

ProductPrinted CFUPrinted doseCost per dayFormGut Index Score
Codeage GLP-Harmony Companion+1,000,000,000not printednot observedCapsule77.50
Codeage Akkermansia100,000,000not printednot observedCapsule77.50
The Akkermansia Company Healthy Weightnot printednot printednot observedTablet or Pill73.00
Codeage GLP-Advantage+not printednot printednot observedCapsule66.25
SuperSmart Akkermansia Muciniphila 1 Billion Cellsnot printednot printednot observedCapsule29.03
Solaray Akkermansia Postbioticnot printednot printednot observedCapsule29.03
Containing labels6
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.

Matched PubMed records

54 records (retracted records excluded; 6 retracted records match the query separately). PubMed query

Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.

  1. 2026 · Sialidase inhibitor modulates gut microbiota and enhances mucosal protection in the treatment of ulcerative colitis.
  2. 2026 · PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.
  3. 2026 · Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels.
  4. 2026 · The Effects of a Prebiotic Formula Promoting Akkermansia muciniphila (AKK) on Gut Health: A Single-Centre, Randomised Controlled Trial.
  5. 2026 · Pasteurized Akkermansia muciniphila Muc(T) for weight loss maintenance in people with overweight and obesity: a controlled randomized trial.
  6. 2026 · Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiota.
  7. 2026 · JK5G postbiotics modulate gut microbiota and metabolome to alleviate cancer-related pain: a randomized controlled trial with multi-omics integration.
  8. 2026 · Efficacy of inulin supplementation in metabolic control and Akkermansia muciniphila levels in subjects with type 1 diabetes: a pilot study.
  9. 2026 · Efficacy and Safety of Gelatin Tannate and Tyndallized Acid Lactic Bacteria in Adults With Chronic Diarrhea and Altered Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Study.
  10. 2025 · A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention.

and 44 more

ClinicalTrials.gov

37 interventional studies. ClinicalTrials.gov query

Strains and species-only SKUs

Species-level observations do not inherit evidence from individual strains. A SKU can have both named-strain and species-only label versions.

Unresolved species-only observations

4 SKUs; 4 label versions. No printed strain designation was extracted for these rows. Showing up to 100 label versions; full SKU and label-ID lists are in the page JSON download.

SKUBrand / productDSLD
sku:akkermansiaCodeage Akkermansia333402
sku:glp-harmony-companionCodeage GLP-Harmony Companion+333410
sku:healthy-weightThe Akkermansia Company Healthy Weight323364
sku:glp-advantageCodeage GLP-Advantage+333409

Axis 1 · inverted

Containing label versions

Showing 6 of 6 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.

BrandProductDSLDGut Index ScoreStrain namedPer-organism quantityPotency basisVersions
CodeageAkkermansia33340277.50false100,000,000 CFUat manufacture1
CodeageGLP-Harmony Companion+33341077.50false1,000,000,000 CFUat manufacture1
The Akkermansia CompanyHealthy Weight32336473.00falsenot printed for this organismnot stated1
CodeageGLP-Advantage+33340966.25falsenot printed for this organismat manufacture1
SuperSmartAkkermansia Muciniphila 1 Billion Cells33232629.03true1,000,000,000 CFUnot stated1
SolarayAkkermansia Postbiotic33838629.03true10,000,000,000 CFUnot stated1

Axis 2

Studiedness

Evidence amount
1.00
Direction balance
The direction of the study results has not been extracted.
PMID records loaded
54
Records after title/year deduplication
54

Axis 3

Measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4

Reddit mention panel

0 observed mentions; no aggregate panel matched this entity.

Elsewhere in this release

Related pages

Compared side by side: Akkermansia muciniphila vs Pendulum Akkermansia

Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps

Tools: DSLD product check · Unit value calculator

Citation

Cite this page

Ivitskiy, I. (2026). Akkermansia muciniphila. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/akkermansia-muciniphila/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. Akkermansia muciniphila appears on 6 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 4 brands; tied with 2 species by distinct label count.

    6 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  2. 5 of 6 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Akkermansia muciniphila (83.3%); 0 light records have quantities unavailable.

    5 / 6 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  3. 54 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 54 records (retracted records excluded; 6 retracted records match the query separately).

    Published PubMed query

    54 / 54 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  4. 37 interventional studies on ClinicalTrials.gov match the published query.

    Published ClinicalTrials.gov query

    37 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  5. 0 of 6 SKUs containing Akkermansia muciniphila have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.

    0 / 6 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub